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In chicken embryo fibroblasts, phosphorylation of the 40S ribosomal protein S6 increases during G1 but
returns to basal level by mitosis. In contrast, in Rous sarcoma virus (RSV)-transformed fibroblasts, S6 remains
highly phosphorylated throughout mitosis. This study investigated the mechanism by which RSV alters the
pattern of S6 phosphorylation. Pulse-chase experiments demonstrate that phosphate turnover in S6 is rapid in
normal cells and in cells infected with an RSV transformation-defective virus. In contrast, phosphate turnover in
S6 is severely reduced in cells infected with temperature-sensitive RSV at a temperature permissive for
transformation, indicating a diminished S6 phosphatase activity. Fractionation of cell lysates by DEAE
chromatography showed an almost threefold lower S6 phosphatase activity in RSV-transformed versus normal
cells. The S6 phosphatase was sensitive to inhibitor 2 and specifically recognized by an antibody to type 1
phosphatase (PP1). The S6 phosphatase activity recovered by immunoprecipitation of PP1 was threefold lower
in transformed cells, but the steady-state level of expression and the rate of synthesis of PP1 were not altered by
oncogenic transformation. Together, the results show that transformation by RSV reduced the S6-PPl activity.
Reversible protein phosphorylation plays a central role in
the control of cell proliferation and depends on the relative
activities of protein kinases and phosphatases. The tyrosine
kinase activity exhibited by a number of growth factor
receptors and oncogene products is critical for induction of
cell growth and malignant transformation (for a review, see
reference 41). Tyrosine phosphorylation of cellular proteins
represents a minor fraction of total protein phosphorylation
(26). Yet, through a series of cascades not fully character-
ized, tyrosine phosphorylation leads to the activation of a
number of serine and threonine kinases. As a result, serine
(threonine) protein phosphorylation increases, constituting
the bulk of cellular protein phosphorylation in response to
growth factors and oncogene products (for a review, see
reference 46).
An early cellular event after mitogenic stimulation or viral
transformation is the multiple and ordered phosphorylation
of the 40S ribosomal protein S6 (5, 35, 36). Phosphorylation
of S6 seems to be a prerequisite for G, progression (45, 47).
It is controlled by the opposing activities of the mitogen-
activated S6 kinase (for a review, see reference 19) and
protein phosphatase type 1 (PP1) (2, 39). The S6 kinase itself
is regulated by phosphorylation, and type 2A phosphatase
(PP2A) specifically inactivates this and other kinases in the
cascade (3, 21).
It is clear that protein phosphatases play a fundamental
role in the control of cellular growth and differentiation (for
reviews, see references 7, 9, 13, 24, and 40). Among serine
and threonine protein phosphatases, the PP1 catalytic sub-
unit, a 37-kDa protein, is one of the most highly conserved
enzymes in eukaryotes (7, 13, 15, 16). PP1 is essential for
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completion of mitosis in lower eukaryotes such as Aspergil-
lus nidulans and Schizosaccharomyces pombe. Further-
more, genetic studies have shown that mutation of genes
homologous to the mammalian PP1 causes mitotic defects in
chromosomal disjunction and separation of nuclei during
anaphase (8, 17, 37). Also in higher eukaryotes, microinjec-
tion of neutralizing anti-PP1 antibodies at the beginning of
mitosis blocks cell division at metaphase (20). In addition,
PP1 is associated with and controls the dephosphorylation of
the retinoblastoma protein (p11ORB) (18, 31), whose state of
phosphorylation through the cell cycle is important for the
control of cell growth (23). In this context, PP1 may be
implicated in cell proliferation and tumor repression.
The nucleotide and amino acid sequences of PP1 show
significant homology with those of the PP2A catalytic sub-
unit (4). However, the differences at the carboxyl terminal
portions of PP1 and PP2A (4, 16) have permitted generation
of specific antipeptide sera for PP1, which does not interfere
with its enzymatic activity (12, 29, 32, 39). Here, we have
examined in chicken embryo fibroblasts the effect of Rous
sarcoma virus (RSV) transformation on the S6 phosphory-
lation and found evidence for a decrease in the specific
activity of PP1-S6 phosphatase.
MATERIALS AND METHODS
Cell culture and labeling. CEF cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) supple-
mented with 5% newborn calf serum (NBCS; Sera-Lab
Limited, Sussex, United Kingdom), 1% chicken serum (Se-
ra-Lab Limited), and antibiotics at 41.5°C. They were in-
fected independently with different mutants of the RSV viral
stocks: wild-type Schmidt-Ruppin subgroup, strain A (wild-
type v-Src; a gift of R. L. Erikson, Harvard University);
ts-NY72-4, a temperature-sensitive mutant of v-Src, and the
td-NY3-15, an N-terminal deletion mutant defective for
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transformation of v-Src (both viral mutants were a gift of H.
Hanafusa, Rockefeller University) (22). Cells were used for
experiments two passages after infection.
For labeling cells with 32pi, cultures in 90-mm-diameter
dishes were incubated with 0.4 mCi of 32p; (carrier free; ICN
Biomedicals, Irvine, Calif.) ml-1 in 5 ml of phosphate-free
medium for the appropriate period of time. For labeling with
[35S]methionine, cells cultured in 60-mm-diameter dishes
were preincubated for 30 min in 2 ml of methionine-free
medium and then radiolabeled with 200 ,uCi of [35S]methio-
nine (Translabel; ICN Biomedicals) ml-' for the time and
temperature indicated in each experiment.
Ribosomal protein extraction and analysis of S6 phosphory-
lation. Ribosomal proteins were extracted from cultured
cells, and phosphorylation of S6 was analyzed by two-
dimensional gel electrophoresis or by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) as pre-
viously described (30, 34, 42).
Assay ofS6 protein phosphatase activity. The test of the S6
protein phosphatase activity was performed with 40S rat
liver ribosomal subunits prepared by zonal centrifugation
and phosphorylated with [y-32P]ATP (ICN Biomedicals;
7,000 Ci/mmol). Cytosolic extracts were used a source of S6
protein kinase as described elsewhere (34), except that
okadaic acid (Boehringer Mannheim) was included in the
lysis buffer to a final concentration of 1 nM. The 32P-40S
ribosomal subunits were repurified by ethanol precipitation
and resuspended in 20 mM Tris-HCl (pH 7.4)-100 mM
KCl-5 mM MgCl2-1 mM 2-mercaptoethanol to a final optical
density at A260 of 15 U/ml, as described elsewhere (34), and
used as a phosphatase substrate.
Partial purification of S6 phosphatase from cellular ex-
tracts. CEF or CEF-ts-NY72-4 cells grown in seven 90-mm-
diameter petri dishes (about 3 x 107 cells) were washed with
5 ml of ice-cold Tris-saline (20 mM Tris-HCl [pH 7.2], 150
mM NaCl) per dish, and then scraped and resuspended in 1
ml of ice-cold homogenization buffer (20 mM Tris-HCl [pH
7.2], 15 mM 2-mercaptoethanol, 0.1 mM EDTA, 1 mM
phenylmethylsulfonylfluoride) and homogenized with 30
strokes of a Dounce homogenizer with a tight-fitting pestle.
The homogenates were centrifuged at 100,000 x g for 2 h,
and the supernatants were adjusted to a final concentration
of 10% glycerol and passed over 7 ml of DEAE cellulose
(Whatman, DE 52) columns equilibrated with homogeniza-
tion buffer containing 10% glycerol. The chromatography
was developed with a 60-ml linear gradient from 30 to 300
mM NaCl. Fractions of 1 ml were collected, and the phos-
phatase activity was measured in every other fraction.
The eluted S6 phosphatase activity was assayed in a final
volume of 25 p1l containing 10 p,l of homogenization buffer, 5
,ul of the corresponding fraction, and 10 ,ul of 32P-40S
ribosomal subunits (optical density at 260 nm, 0.15). After
incubation for 10 min at 30°C, the reaction was stopped by
addition of 6 pl of 5x SDS-sample buffer; the reaction
mixture was boiled for 3 min, and the proteins were resolved
by SDS-15% PAGE (30). The gels were dried and exposed to
Kodak X-Omat film at -70°C, with the addition of a pair of
Cronex Lightning-Plus intensifying screens (Du Pont Co.,
Wilmington, Del.). Finally, the bands corresponding to
32P-S6 were excised and their content in 32p was quantified
by scintillation counting. When inhibitor 2 was used, the
samples were preincubated at 30°C for 10 min with 1 p,g of
purified inhibitor 2 (48) before the addition of the substrate.
Analysis of PP1 by immunoprecipitation and immunoblot-
ting. Immunoprecipitation and immunoblotting of PP1 from
cell extracts were carried out with an anti-PP1-peptide serum
5
4
C.)
0 3
E
2
0 6 8 10
TIME (hours)
16
FIG. 1. S6 phosphorylation in normal and RSV-transformed
cells. Quiescent cultures of CEF and CEF-ts-NY72-4 at 41.5°C were
stimulated by shifting both from 41.5 to 35°C plus the addition of
10% serum to CEF in the presence of 0.4 mCi of 32Pi ml-1. At the
indicated times, ribosomes were isolated from cell lysates and
loaded in an SDS-15% PAGE, the 32P-S6 band was excised, and
radioactivity was determined by scintillation counting after autora-
diography of the gel. 0, CEF; *, CEF-ts-NY72-4.
generated against the 14 C-terminal amino acid residues of
PPlc (a gift of A. Olivier and G. Thomas, Friedrich Miescher
Institute) as described previously (39).
Assay of phosphorylase a phosphatase activity. Phosphory-
lase b and phosphorylase kinase were purified from rabbit
skeletal muscle and used to prepare [ P]phosphorylase a
with a specific activity of 3 x 103 to 5 x 10 dpm/pmol (14).
The protein phosphatase activity of the immunoprecipitates
from cell lysates was determined as described previously
(39).
RESULTS
Early studies had suggested that S6 phosphorylation is
differentially regulated in normal versus v-Src-transformed
chicken embryo fibroblasts (33). To examine this possibility
more closely, S6 phosphorylation was measured in normal
chicken embryo fibroblasts (CEF) following serum stimula-
tion and in CEF-ts-NY72-4, transformed with a temperature-
sensitive mutant of p60vsrC, after simultaneously shifting the
cell cultures from the nonpermissive temperature (41.5°C) to
the permissive temperature (35°C). Under these two condi-
tions, cultures grew at similar rates, with a doubling time of
16 h (data not shown). As shown in Fig. 1, the increase in the
incorporation of 32p label into S6 during the G1 phase of the
cell cycle was comparable in normal and transformed cells.
However, whereas in CEF cells the levels of S6 phosphory-
lation returned to basal levels by mitosis, in CEF-ts-NY72-
4-transformed cells they remained high throughout the time
course. The observation suggested that oncogenic transfor-
mation could alter the activity of either the kinase or a
phosphatase involved in regulating the levels of S6 phos-
phorylation.
CEF cells transformed by v-Src showed an activation of
the S6 kinase comparable to that found when grown with a
saturating concentration of serum (6). This result suggested
that the high levels of S6 phosphorylation detected in trans-
formed cells (Fig. 1) reflected a decrease of S6 phosphatase
activity rather than an increase of S6 kinase activity. To test
this hypothesis, we studied the dephosphorylation of S6 by
examining the turnover of the 32P; incorporated into S6
during the G1 phase. In pulse-chase experiments, we could
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FIG. 3. Analysis of 32P-S6 turnover in transformation-defective
mutants of v-Src. The turnover of 32p in S6 from CEF (A),
CEF-ts-NY72-4 (B), and CEF-td-NY3-15 (C) was analyzed by pulse
labeling of cells with 32P, followed by a chase period with nonradio-
active Pi, as described in figure legend 2. Quiescent cultures of CEF,
CEF-ts-NY72-4, and CEF-td-NY3-15 at 41.5°C were pulsed with
32pi (0.4 mCi/ml) in phosphate-free DMEM for 2 h coincident with
stimulation by shifting the temperature to 35°C plus the addition of
10% serum to CEF and CEF-td-NY3-15. S6 phosphorylation was
analyzed by SDS-15% PAGE, the gels were autoradiographed, and
for quantification the S6 bands were excised and radioactivity was
determined by scintillation counting. Lanes 1 show the incorpora-
tion of 32p; into S6 during the 2-h pulse period. Lanes 2 show the
labeling of S6 after a chase of 32p for 2 h, carried out at 35°C in
complete DMEM and in the presence of 10% serum for CEF and
CEF-td-NY3-15 cells. Lanes 3 show the labeling of S6 after chase
for 2 h at 41.5°C in complete DMEM and serum-deprived CEF and
CEF-td-NY3-15 cells.
FIG. 2. Pulse-chase labeling of cells to observe turnover of
phosphate in S6. Quiescent cultures of CEF and CEF-ts-NY72-4 at
41.5°C were stimulated by shifting both to 35°C plus the addition of
10% serum to CEF in the presence of 0.4 mCi of 32Pi ml-' in
phosphate-free DMEM. After 2 h, 9 x 106 cells of each type were
lysed and the extent of S6 phosphorylation was analyzed by
two-dimensional gel electrophoresis. These experiments are de-
picted by Coomassie blue patterns of CEF (A) and CEF-ts-NY72-4
(C) and by autoradiography of CEF (B) and CEF-ts-NY72-4 (D). For
pulse and chase experiments, two other sets of each cell type were
washed four times with prewarmed complete DMEM. One set was
maintained under stimulated conditions but without 32Pi for another
2 h, and then S6 phosphorylation was analyzed as above: by
Coomassie blue patterns of CEF (E) and CEF-ts-NY72-4 (G) and by
autoradiography of CEF (F) and CEF-ts-NY72-4 (H). The other set
of cells was also chased for 2 h as described above but at 41.5°C and
with serum-deprived CEF. Coomassie blue patterns of CEF (I) and
CEF-ts-NY72-4 (K) and autoradiography of CEF (J) and CEF-ts-
NY72-4, (L) are shown.
determine, on the basis of electrophoretic migration by
two-dimensional gel electrophoresis (47), the turnover of S6
phosphorylation by comparing the radiolabeling of S6 (auto-
radiography) to its overall phosphorylation state (Coomassie
blue staining pattern).
In quiescent cells, S6 exists mostly in the dephosphory-
lated state (47; data not shown). Stimulation of cells for 2 h
by the addition of serum or by activation of the ts-v-src
oncogene induced increased S6 phosphorylation to a similar
extent. This response was observed by the appearance of
five new acidic forms of the protein, named a, b, c, and d-e,
representing the incorporation of 1 to 5 mol of phosphate (36)
(Fig. 2A and C, protein staining patterns; B and D, corre-
sponding autoradiograms).
When the 32Pi was chased with unlabeled phosphate for 2
h at 35°C in the continued presence of serum for normal
cells, conditions that maintained the S6 kinase active (6, 44),
overall S6 phosphorylation increased in both cases towards
the most highly phosphorylated S6 derivatives (d and e) (Fig.
2E versus A and G versus C), with a marked decrease in the
less phosphorylated forms of S6 (a and b). However, when
the incorporation of 32p; into S6 at the end of the pulse period
was estimated as 100%, normal cells showed a reduction of
32P-labeled S6 between 50 and 75% at the end of the 2-h
chase period, determined by excising and counting the S6
band from SDS gels in four different experiments (Fig. 2F
versus B and Fig. 3A, lane 2 versus lane 1). In contrast,
transformed cells showed little or no decrease (0 to 20%; n =
4) in the levels of 32P-S6 during the same chase period (Fig.
2H versus D and Fig. 3B, lane 2 versus lane 1). The meaning
of those differences was confirmed by performing similar
experiments in normal and transformed cells incubated for 2
h without serum and at a nonpermissive temperature of
41.5°C, respectively, conditions that were expected to inac-
tivate S6 kinase (6). Under those conditions, cells returned
to a quiescent state and S6 protein was dephosphorylated, as
indicated by the predominance of the unphosphorylated
form and the forms a and b which contained only 1 and 2 mol
of phosphate, respectively (Fig. 2I and K, Coomassie blue
staining). Furthermore, the 32p present in S6 was reduced by
80% in normal cells (Fig. 2J versus B and Fig. 3A, lane 3
versus lane 1) and, more important, by 40% in the trans-
formed cells (Fig. 2L versus D and Fig. 3B, lane 3 versus
lane 1). Since the rates of the S6 kinase inactivation were
very similar for serum-deprived normal cells and for trans-
formed cells transferred to a nonpermissive temperature
(data not shown), it suggested that the S6 phosphatase
activity was higher in normal than in transformed cells under
those chase conditions. To exclude the possibility that the
differences in the loss of 32P-S6 content between normal
serum-stimulated and v-Src-transformed cells simply re-
flected differences in ribosomal turnover, we performed a
similar pulse-chase experiment with [35S]methionine. No
ribosomal degradation was detected during the chase period
in which the differences in 32P-S6 turnover were detected
(data not shown). Furthermore, a control study of the
ATPase activity revealed no differences between normal and
transformed cells (data not shown). These results strongly
suggested that v-Src transformation inhibited S6 phos-
phatase activity.
To determine whether the above observations were spe-
cific to oncogenic transformation and not a consequence of
viral infection, a pulse-chase experiment was carried out
with CEF cells infected with td-NY3-15, a transformation-
defective mutant of the v-src oncogene. td-NY3-15 encodes
for a p60v-sc with a deletion at the N terminus, such that the
oncogene product retains tyrosine kinase activity but is
cytosolic (22). The results showed that the CEF-td-NY3-15-
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FIG. 4. S6 phosphatase activity in CEF and CEF-ts-NY72-4.
Quiescent cultures of CEF and CEF-ts-NY72-4 at 41.5°C were
stimulated by shifting both to 35°C plus the addition of 10% serum to
CEF. After 4 h, the supernatants of the cell homogenates, normal-
ized for the amounts of protein, were applied to DEAE columns and
the fractions were tested for S6 phosphatase activity with 32P-40S
ribosomes (32P-S6) in the absence or in the presence of inhibitor 2.
U, CEF; 0, CEF-ts-NY72-4. The S6 phosphatase activity is pre-
sented as percent of S6 dephosphorylation (% S6 dP). The peaks of
S6 phosphatase activity were concentrated on small DEAE columns
and loaded in SDS-15% PAGE, and proteins were transferred to
nitrocellulose and probed with the anti-PP1 polyclonal antibody.
The immunoblot is shown in the inset. UN, uninfected CEF; RSV,
CEF-ts-NY72-4.
infected cells behaved similarly to normal CEF cells, dis-
playing a turnover of 60% of the phosphate incorporated to
S6 during the chase period (Fig. 3A and C). Therefore, the
lack of 32P-label turnover in S6 was specific to transformed
cells in which the p6OvsrC is active and localized to the
membrane and cytoskeleton.
The higher stability of the 32P-S6 in v-Src-transformed
cells suggested a decrease in normal levels of S6 phos-
phatase activity. To test for S6 phosphatase in vitro, CEF
and CEF-ts-NY72-4 were stimulated for 4 h as described
above, the same length of time as the pulse-plus-chase
periods. Equal amounts of protein from the supernatants of
each aliquot of cell lysates was analyzed by DEAE chroma-
tography. The fractions were tested for S6 phosphatase
activity by using phosphorylated 40S ribosomal subunits as
the substrate (see Materials and Methods). A major peak of
phosphatase activity was eluted at 130 mM NaCl from
normal and transformed cells (Fig. 4). Quantification of the
activity showed that in ts-NY72-4-transformed cells the
levels of S6 phosphatase were nearly threefold lower than
those in normal cells. When the assay was performed in the
presence of the PP1 inhibitor, inhibitor 2, the S6 phosphatase
activity was completely blocked (Fig. 4, basal line), indicat-
ing that the enzyme was a PP1, in agreement with previous
results (2, 39). The amounts of the 37-kDa PP1 catalytic
subunit recovered after DEAE chromatography, as mea-
sured by immunoblot analysis using a specific polyclonal
anti-PP1 (10), were the same for normal and transformed
cells (Fig. 4, inset), which suggests an inhibition of PP1
activity rather than a decrease of its expression.
We have further analyzed whether cellular transformation
by v-Src could modify the expression of PP1. Since the
catalytic subunits of PP1 and PP2A have several regions in
their primary sequences that are identical (4), to discard the
possibility that changes in the protein levels of the PP1-S6
phosphatase could be masked by fluctuations in PP2A, we
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FIG. 5. (A) Immunoblotting of PP1 in lysates of normal and
RSV-transformed cells. Immunoblotting was used to detect PP1
levels in total cellular proteins of normal uninfected (UN) and
v-Src-transformed cells (RSV). Cells were directly lysed in 2x SDS
sample buffer, and three samples, each containing equal amounts of
protein (100, 50, and 25 pLg [lanes 1, 2, and 3, respectively]), from
UN and RSV were loaded in SDS-15% PAGE, transferred to
nitrocellulose, and probed with the anti-PP1-peptide antibody, incu-
bated with "2I-donkey anti-rabbit immunoglobulin G, and subjected
to autoradiography. The purified rabbit protein PP1 was used as a
control (arrow). (B) Analysis of PP1 expression in normal and
RSV-transformed cells. Exponentially growing cultures of normal
uninfected (UN) and v-Src-transformed (RSV) cells were labeled
with [35S]methionine for 2 h. Cell lysates, normalized for the amount
of protein, were immunoprecipitated with a nonimmune serum (NI)
or with the anti-PP1-peptide serum (I). The immunoprecipitates
were analyzed by SDS-15% PAGE, and a photograph of the
fluorograph is shown. Molecular markers (in kilodaltons) are at the
left. The PP1 (arrow) is at the right.
used, in the following experiments, an antiserum generated
against the last 14 amino acids of the PP1 catalytic subunit,
which have been shown to be specific for PP1 and which
allow determination of phosphatase activity after immuno-
precipitation (39). The steady-state expression of PP1 was
measured by immunoblotting. Titration of total lysates of
normal and v-Src-transformed cells showed that the amounts
of PP1 were identical for both cell types (Fig. SA). These
results demonstrate that oncogenic transformation did not
modify the steady-state levels of PP1 expression but did not
exclude the possibility that v-Src could alter its rate of
synthesis. To test this possibility, PP1 was immunoprecipi-
tated from equal amounts of protein cell lysates extracted
from exponentially growing normal and v-Src-transformed
CEF cells pulse-labeled for 2 h with [35S]methionine. A
37-kDa protein band, corresponding to the catalytic subunit
of PP1, was specifically immunoprecipitated (Fig. 5B). Since
the intensity of this band was the same for both cell lysates,
it can be argued that the rate of synthesis of PP1 was not
altered by oncogenic transformation.
The bulk of data indicated that v-Src transformation
inhibited PP1 specific activity; however, it cannot be ex-
cluded that a factor coeluting with the phosphatase in the
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FIG. 6. Quantification and activity of PP1 in immunoprecipitates
from normal and v-Src-transformed CEF. Total cell lysates from
exponentially growing cultures of normal uninfected (UN) and
wild-type v-Src-transformed CEF (RSV), adjusted for equal
amounts of protein, were immunoprecipitated with nonimmune
serum and subsequently with the anti-PPl-peptide serum (I); after
several washes the immune complexes were incubated on ice for 1
h with an excess of the antigenic peptide (10 ,uM) and the proteins
dissociated from the immune complexes were separated by centrif-
ugation. An aliquot of these supernatants for each cell type was
assayed for PP1 activity by incubation with in vitro 32P-labeled 40S
ribosomal subunits (32P-S6) or with phosphorylase a for 10 min at
30°C, followed by analysis by SDS-10% PAGE and autoradiography
of the 32P-S6 (panel 1) and the [32P]phosphorylase a (panel 2). Line
C shows the amounts of 32P-S6 or [ 2P]phosphorylase a used in the
assay. The other aliquot of the supernatants from each cell type was
run in SDS-15% PAGE, and proteins were transferred to nitrocel-
lulose and probed with the anti-PPl-peptide serum (panel 3).
DEAE chromatography could be responsible for the de-
crease of activity. We have, therefore, taken advantage of
the specific antipeptide serum and measured the activity and
amounts of PP1 after immunoprecipitation. Cell lysates of
both cell types, normalized for the amount of protein, were
immunoprecipitated with an excess of antibody, and after
several washes, the immune complexes were incubated on
ice with an excess of the antigenic peptide (10 ,uM) as
described previously (39). Equal aliquots of the material
displaced by the peptide from the immune complexes were
then assayed for PP1 activity by using two substrates: in
vitro phosphorylated 40S ribosomal subunits containing 32P-
S6, and in vitro-labeled [32P]phosphorylase a, a standard
substrate for PP1 (14). The antigenic peptide released higher
levels of PP1 activity from normal than from transformed
cells, as tested on both substrates S6 and phosphorylase a
(Fig. 6, panels 1 and 2). The PP1 activity of normal versus
transformed cells was significantly higher for S6 than for
phosphorylase a, indicative of a PP1. The amount of PP1 in
these samples was determined by immunoblotting of another
aliquot of the same peptide-eluted immune complexes. It
was found, once again, that normal and transformed cells
expressed the same amounts of PP1 catalytic subunit (Fig. 6,
panel 3). The results demonstrate that cellular transforma-
tion by v-Src decreased the activity of PP1 without affecting
the protein levels of the enzyme.
DISCUSSION
Here, we present data demonstrating attenuation of the S6
protein phosphatase activity in v-Src-transformed CEF.
Comparison was made between normal CEF cells and cells
infected with either a temperature-sensitive virus (ts-
NY72-4) or a transformation-defective virus (td-NY3-15).
S6 phosphorylation was increased during the G1 phase of
the growth cycle in ts-NY72-4-CEF transferred to a permis-
sive temperature and in normal cells stimulated by the
addition of serum. This is consistent with previous reports
showing that in CEF both pp6OvsrC and serum activated S6
kinase and increased the overall extent of S6 phosphoryla-
tion (for a review see reference 19), which seems to be an
important requisite for cell proliferation during G1 (45, 47).
However, we found that in normal cells S6 phosphorylation
returned to basal levels at mitosis, while it remained high in
v-Src-transformed cells. That the longer-term differences in
S6 phosphorylation could result from changes in S6 phos-
phatase activity must be considered, but this possibility has
not yet been explored.
32P pulse-chase experiments support this initial consider-
ation. The Coomassie blue-stained pattern and autoradio-
grams of S6 on two-dimensional gels from the pulse period
showed that v-Src or serum activates the S6 kinase and, as a
consequence, increases S6 phosphorylation. During the
chase period, in normal serum-stimulated cells the reduction
in the amount of 32p label of S6 was greater than 50%, as
shown by the corresponding autoradiogram. In contrast, the
overall state of S6 phosphorylation increased, as detected in
the Coomassie blue-stained gel. This observation was con-
sistent with a substantial level of S6 phosphatase activity in
normal cells, and rapid cycling between phosphorylated and
dephosphorylated S6, with activated S6 kinase predominat-
ing to accumulate the highly phosphorylated form of S6. In
contrast, ts-NY72-4-transformed cells did not show a de-
crease in 32p labeling of S6 during the chase period, revealing
a new and important difference between normal and v-Src-
transformed cells. The td-NY3-15 gave the same response as
normal cells. Moreover, no differences were detected in the
rates of ribosomal turnover or in ATPase activities of normal
and v-Src-transformed cells (data not shown). Therefore, the
inhibition of 32P-S6 turnover in transformed cells must be a
consequence of the oncogenic properties of v-Src. Changing
the ts-NY72-4-infected cells from 35 to 41.5°C produced
a rapid shift between the transformed and nontransformed
states and inactivation of both the oncogenic protein
pp60'-v-src and the S6 kinase (6). Since the rates of S6 kinase
inactivation during the chase protocol in serum-deprived
normal cells and in transformed cells transferred to a non-
permissive temperature were very similar (data not shown),
the differences in the rate of S6 dephosphorylation between
both cells under these conditions were mainly a consequence
of a higher activity of the S6 phosphatase in normal cells.
Together, these results clearly indicate a lower level of in
vivo S6 phosphatase activity in v-Src-transformed cells.
The specific activity of PP1 was lower in transformed
cells. The S6 phosphatase activity detected after DEAE
chromatography fractionation of cell lysates was blocked by
inhibitor 2 and reactive with the PP1 antibody by immuno-
blotting, confirming that the S6 phosphatase was PP1, as
previously reported (2, 39). Transformation reduced the PP1
specific activity, because there was approximately one-third
of the S6 phosphatase activity but the same amount of PP1
detected in normal cells, as measured by immunoblotting
after DEAE chromatography in both cell types. This result
was supported by the analysis of the steady-state level of
expression and the fact that the rate of synthesis of PP1 did
not change after v-Src transformation of normal cells. It
could be argued, however, that in transformed cells PP1
activity was reduced by complex formation between the
catalytic subunit and cognate regulatory subunits or inhibitor
proteins, e.g., inhibitor 1 and inhibitor 2 (1, 7, 13). Gel
filtration analysis of cell extracts from normal and trans-
formed cells revealed identical elution profiles of PP1 activ-
ity (data not shown), suggesting that the reduced activity
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was not caused by the interaction of the catalytic subunit of
PP1 with different cellular regulatory proteins. This is also
supported by the protein patterns of PP1 immunoprecipita-
tion from [35S]methionine pulse-labeled cells, for which no
differences were detected between normal and transformed
cells.
It has been shown that phosphorylation of PP1 catalytic
subunit by purified oncogenic tyrosine kinases could de-
crease its activity (27, 28, 49). It was, therefore, an obvious
possibility to explore. The immunoprecipitation of PP1 with
the antipeptide serum from 32Pi-labeled normal and v-Src-
transformed cells revealed a 37-kDa protein that was phos-
phorylated to the same extent in both cell types, but phos-
photyrosine was not detected in the immunoprecipitated
37-kDa phosphoprotein, which was mainly serine phos-
phorylated in both normal and v-Src-transformed CEF (data
not shown). Thus, the decrease of PP1 activity in trans-
formed cells was not produced by direct pp6o-src phospho-
rylation. It is relevant to indicate that modulation of the S6
phosphatase in 3T3 cells by serum was reported to involve
the PP1 catalytic subunit in association with two phos-
phoproteins of 26 and 48 kDa (39). In the fission yeast,
mutations in dis2 and sds2l, the PP1 homologs in this
species, are suppressed by Sds22. The interaction alters the
substrate specificity because the complex of Sds22:PP1 has
histone phosphatase but not phosphorylase phosphatase
activity (43). The Sds22 protein is reported to be phospho-
rylated in cells, and it is conceivable that the Sds22 homolog
in mammals is the 48-kDa phosphoprotein that coimmuno-
precipitates with PP1. Targeting subunits have been also
implicated in PP1 specificity in skeletal and smooth muscle
(1). We also observed a selective effect of PP1 inhibition in
transformed cells, since the activity of PP1 in normal cells
for 32P-S6 was higher than that detected for [32P]phosphory-
lase a compared with PP1 activity in transformed cells. We
can speculate that the regulation of PP1 observed here
specifically reduced S6 phosphatase activity, but constant
phosphorylase phosphatase activity in v-Src-transformed
cells could involve a posttranslational modification, i.e.,
phosphorylation or dephosphorylation, of a targeting and/or
regulatory protein associated with the PP1 catalytic subunit.
Here, we did not detect the 26- and 48-kDa phosphoproteins,
perhaps revealing differences in the regulatory mechanisms
of PP1 of birds and mammals. Nevertheless, a causal rela-
tionship between phosphorylation of the 37- or the 26- and
48-kDa proteins and the activity of PP1 now needs to be
established.
The measurements of the activity and amounts of PP1
determined after its immunoprecipitation from normal and
transformed cells with the anti-PP1 peptide serum showed
that while the amounts of PP1 catalytic subunit were identi-
cal for both cell types, v-Src provoked an inhibition of this
phosphatase activity, clearly demonstrating that cellular
transformation by v-Src inhibits PP1-specific activity com-
pared with the activity found with serum growth factors in
normal cells.
In view of the fact that PP1 plays a crucial role in growth
control (8, 17, 18, 20, 23, 31, 37) and that insulin and growth
factors are reported to stimulate PP1 activity (11, 38), the
inhibition of PP1 by v-Src could be relevant in the mecha-
nisms of aberrant cellular growth induced by this oncogene.
In addition, since PP1 is highly expressed in the nuclei (7)
and many transcription factors are regulated by phosphory-
lation (25), the inhibition of PP1 might be implicated, in part,
in the alteration of gene expression provoked by v-Src.
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